Dipannita Basu Selected Research

3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamide

4/2015	Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA.
4/2013	Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia.
1/2013	Effects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalization.
1/2011	PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dipannita Basu Research Topics

Disease

6	Schizophrenia (Dementia Praecox) 04/2015 - 01/2011
1	Parkinson Disease (Parkinson's Disease) 05/2013

Drug/Important Bio-Agent (IBA)

4	3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamideIBA 04/2015 - 01/2011
4	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2013 - 01/2011
2	Synapsins (Synapsin I)IBA 04/2015 - 05/2012
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 05/2012
2	PeptidomimeticsIBA 04/2013 - 01/2011
1	Therapeutic UsesIBA 04/2015
1	Protein Isoforms (Isoforms)IBA 05/2013
1	MSH Release-Inhibiting Hormone (MIF-I)IBA 04/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Messenger RNA (mRNA)IBA 05/2012
1	PhosphoproteinsIBA 05/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2011
1	prolylleucineIBA 01/2011
1	glycine amideIBA 01/2011

Therapy/Procedure

1	Therapeutics 04/2015